CGC
Price
$1.37
Change
-$0.02 (-1.44%)
Updated
Sep 12 closing price
Capitalization
427.63M
55 days until earnings call
HCM
Price
$17.93
Change
+$1.56 (+9.53%)
Updated
Sep 12 closing price
Capitalization
2.78B
62 days until earnings call
Interact to see
Advertisement

CGC vs HCM

Header iconCGC vs HCM Comparison
Open Charts CGC vs HCMBanner chart's image
Canopy Growth
Price$1.37
Change-$0.02 (-1.44%)
Volume$14.8M
Capitalization427.63M
HUTCHMED (China)
Price$17.93
Change+$1.56 (+9.53%)
Volume$92.78K
Capitalization2.78B
CGC vs HCM Comparison Chart in %
Loading...
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGC vs. HCM commentary
Sep 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGC is a StrongBuy and HCM is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 13, 2025
Stock price -- (CGC: $1.37 vs. HCM: $17.93)
Brand notoriety: CGC: Notable vs. HCM: Not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CGC: 73% vs. HCM: 179%
Market capitalization -- CGC: $427.63M vs. HCM: $2.78B
CGC [@Pharmaceuticals: Generic] is valued at $427.63M. HCM’s [@Pharmaceuticals: Generic] market capitalization is $2.78B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $65.68B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGC’s FA Score shows that 0 FA rating(s) are green whileHCM’s FA Score has 1 green FA rating(s).

  • CGC’s FA Score: 0 green, 5 red.
  • HCM’s FA Score: 1 green, 4 red.
According to our system of comparison, HCM is a better buy in the long-term than CGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGC’s TA Score shows that 5 TA indicator(s) are bullish while HCM’s TA Score has 5 bullish TA indicator(s).

  • CGC’s TA Score: 5 bullish, 5 bearish.
  • HCM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both CGC and HCM are a good buy in the short-term.

Price Growth

CGC (@Pharmaceuticals: Generic) experienced а -6.16% price change this week, while HCM (@Pharmaceuticals: Generic) price change was +12.27% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.26%. For the same industry, the average monthly price growth was +4.29%, and the average quarterly price growth was +53.41%.

Reported Earning Dates

CGC is expected to report earnings on Nov 07, 2025.

HCM is expected to report earnings on Nov 14, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.26% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HCM($2.78B) has a higher market cap than CGC($428M). HCM YTD gains are higher at: 24.427 vs. CGC (-50.000). HCM has higher annual earnings (EBITDA): 38M vs. CGC (-410.31M). HCM has more cash in the bank: 1.37B vs. CGC (144M). HCM has less debt than CGC: HCM (93.4M) vs CGC (328M). HCM has higher revenues than CGC: HCM (602M) vs CGC (275M).
CGCHCMCGC / HCM
Capitalization428M2.78B15%
EBITDA-410.31M38M-1,080%
Gain YTD-50.00024.427-205%
P/E RatioN/A6.77-
Revenue275M602M46%
Total Cash144M1.37B11%
Total Debt328M93.4M351%
FUNDAMENTALS RATINGS
CGC vs HCM: Fundamental Ratings
CGC
HCM
OUTLOOK RATING
1..100
6957
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9919
PRICE GROWTH RATING
1..100
5050
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CGC's Valuation (50) in the Agricultural Commodities Or Milling industry is in the same range as HCM (50) in the Pharmaceuticals Major industry. This means that CGC’s stock grew similarly to HCM’s over the last 12 months.

CGC's Profit vs Risk Rating (100) in the Agricultural Commodities Or Milling industry is in the same range as HCM (100) in the Pharmaceuticals Major industry. This means that CGC’s stock grew similarly to HCM’s over the last 12 months.

HCM's SMR Rating (19) in the Pharmaceuticals Major industry is significantly better than the same rating for CGC (99) in the Agricultural Commodities Or Milling industry. This means that HCM’s stock grew significantly faster than CGC’s over the last 12 months.

HCM's Price Growth Rating (50) in the Pharmaceuticals Major industry is in the same range as CGC (50) in the Agricultural Commodities Or Milling industry. This means that HCM’s stock grew similarly to CGC’s over the last 12 months.

HCM's P/E Growth Rating (98) in the Pharmaceuticals Major industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that HCM’s stock grew similarly to CGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CGCHCM
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
76%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
73%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 16 days ago
80%
Bullish Trend 1 day ago
74%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 3 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 4 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACGGX24.27N/A
N/A
American Century Global Gold A
JCNAX30.84N/A
N/A
Janus Henderson Contrarian A
MGLBX31.93N/A
N/A
Marsico Global
PMYRX13.22N/A
N/A
Victory Pioneer Equ Premium Income Y
WVMRX11.89N/A
N/A
William Blair Mid Cap Value R6

HCM and

Correlation & Price change

A.I.dvisor tells us that HCM and ACET have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HCM and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HCM
1D Price
Change %
HCM100%
+9.53%
ACET - HCM
29%
Poorly correlated
-8.14%
TLRY - HCM
27%
Poorly correlated
+5.66%
CGC - HCM
27%
Poorly correlated
-1.44%
SNDL - HCM
25%
Poorly correlated
+0.84%
IRWD - HCM
24%
Poorly correlated
+5.65%
More